Manabu Nakamoto

Title: Manabu Nakamoto: Innovator in Monoclonal Antibodies

Introduction

Manabu Nakamoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has advanced the detection and analysis of human calcitonin.

Latest Patents

Nakamoto's latest patents include innovative technologies related to anti-human calcitonin monoclonal antibodies. One patent discloses an immunoassay utilizing monoclonal antibodies that have a high affinity for human calcitonin, specifically suitable for a sandwich immunoassay. This technology allows for the determination of human calcitonin levels in blood samples. Another patent focuses on a monoclonal antibody that specifically recognizes the N-terminal portion of human calcitonin. This invention includes a hybridoma producing the monoclonal antibody, a process for its preparation, and a method for detecting human calcitonin using this antibody, which permits high sensitivity in detection.

Career Highlights

Manabu Nakamoto is associated with Osaka Gas Company Limited, where he applies his expertise in immunology and biotechnology. His work has been instrumental in developing advanced diagnostic tools that enhance the understanding of human health.

Collaborations

Nakamoto has collaborated with notable colleagues, including Nobuhiko Yamashita and Ryoichi Okura. Their combined efforts have contributed to the advancement of research in monoclonal antibodies and their applications in medical diagnostics.

Conclusion

Manabu Nakamoto's innovative work in the field of monoclonal antibodies has led to significant advancements in the detection of human calcitonin. His contributions continue to impact the medical and scientific communities positively.